Liminatus Pharma, Inc. SEC EDGAR Filings (CIK 0001971387)

SEC EDGAR filings, ownership reports, and insider transactions for Liminatus Pharma, Inc..

Symbol
LIMN, LIMNW on Nasdaq
Industry
Biological Products, (No Disgnostic Substances) (Office Of Life Sciences)
Business address
6 Centerpointe Dr., #625, La Palma, CA, 90623
State of incorporation
DE
Fiscal year end
31 December
Former names
Iris Parent Holding Corp. (to 07 Feb 2025)
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
Liminatus Pharma, Inc. has filed 73 SEC EDGAR filings since 02 May 2023

Latest Filings

Recent SEC filings for Liminatus Pharma, Inc. including 8-K, 10-Q, 3 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 25 Nov 2025 19 Nov 2025 001-42626
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 14 Nov 2025 30 Sep 2025 001-42626
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 06 Oct 2025 30 Jun 2025 001-42626
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 25 Aug 2025 22 Aug 2025 001-42626
3 Open 3 document View SEC filing for 3 PRIMARY DOCUMENT 15 Aug 2025 30 Apr 2025
NT 10-Q Open NT 10-Q document View SEC filing for NT 10-Q NT 10-Q 15 Aug 2025 30 Jun 2025 001-42626
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 14 Aug 2025 14 Aug 2025 001-42626
424B3 Open 424B3 document View SEC filing for 424B3 424B3 13 Aug 2025 333-288289
EFFECT Open EFFECT document View SEC filing for EFFECT 12 Aug 2025 333-288289
CORRESP Open CORRESP document View SEC filing for CORRESP 11 Aug 2025
S-1/A Open S-1/A document | Open XBRL data View SEC filing for S-1/A S-1/A 28 Jul 2025 333-288289
CORRESP Open CORRESP document View SEC filing for CORRESP 25 Jul 2025
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 23 Jul 2025 10 Jul 2025
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 21 Jul 2025 10 Jul 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 17 Jul 2025 16 Jul 2025 001-42626
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 11 Jul 2025 10 Jul 2025 001-42626
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 03 Jul 2025 333-288289
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 03 Jul 2025 02 Jul 2025 001-42626
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 27 Jun 2025 005-95001
3 Open 3 document View SEC filing for 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 27 Jun 2025 30 Apr 2025
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 26 Jun 2025 005-95001
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 26 Jun 2025 005-95001
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 26 Jun 2025 005-95001
S-1 Open S-1 document | Open XBRL data View SEC filing for S-1 S-1 24 Jun 2025 333-288289
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 24 Jun 2025 24 Jun 2025 001-42626
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 24 Jun 2025 23 Jun 2025 001-42626
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 16 Jun 2025 30 Apr 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 04 Jun 2025 29 May 2025 001-42626
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 02 Jun 2025 31 Mar 2025 001-42626
8-K/A Open 8-K/A document | Open XBRL data View SEC filing for 8-K/A FORM 8-K/A 02 Jun 2025 30 Apr 2025 001-42626
NT 10-Q Open NT 10-Q document View SEC filing for NT 10-Q NT 10-Q 15 May 2025 31 Mar 2025 001-42626
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 08 May 2025 005-95001
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 07 May 2025 005-95001
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 06 May 2025 30 Apr 2025 001-42626
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 01 May 2025 30 Apr 2025
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 30 Apr 2025 30 Apr 2025
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 30 Apr 2025 30 Apr 2025
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 30 Apr 2025 30 Apr 2025
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 30 Apr 2025 30 Apr 2025
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 30 Apr 2025 30 Apr 2025
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 30 Apr 2025 30 Apr 2025
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 30 Apr 2025 30 Apr 2025
8-K12B Open 8-K12B document | Open XBRL data View SEC filing for 8-K12B 8-K12B 30 Apr 2025 30 Apr 2025 001-42626
424B3 Open 424B3 document View SEC filing for 424B3 424B3 07 Feb 2025 333-275409
EFFECT Open EFFECT document View SEC filing for EFFECT 06 Feb 2025 333-275409
CORRESP Open CORRESP document View SEC filing for CORRESP 04 Feb 2025
POS AM Open POS AM document View SEC filing for POS AM POS AM 27 Jan 2025 333-275409
CORRESP Open CORRESP document View SEC filing for CORRESP 27 Jan 2025
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 23 Jan 2025 333-275409
POS AM Open POS AM document View SEC filing for POS AM POS AM 16 Jan 2025 333-275409
CORRESP Open CORRESP document View SEC filing for CORRESP 15 Jan 2025
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 05 Dec 2024 333-275409
POS AM Open POS AM document View SEC filing for POS AM POS AM 08 Nov 2024 333-275409
424B3 Open 424B3 document View SEC filing for 424B3 424B3 12 Aug 2024 333-275409
EFFECT Open EFFECT document View SEC filing for EFFECT 09 Aug 2024 333-275409
CORRESP Open CORRESP document View SEC filing for CORRESP 09 Aug 2024
S-4/A Open S-4/A document View SEC filing for S-4/A S-4/A 09 Aug 2024 333-275409
S-4/A Open S-4/A document View SEC filing for S-4/A S-4/A 09 Aug 2024 333-275409
CORRESP Open CORRESP document View SEC filing for CORRESP 08 Aug 2024
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 08 Aug 2024 377-06696
S-4/A Open S-4/A document View SEC filing for S-4/A S-4/A 07 Aug 2024 333-275409
CORRESP Open CORRESP document View SEC filing for CORRESP 07 Aug 2024
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 05 Aug 2024 377-06696
S-4/A Open S-4/A document View SEC filing for S-4/A S-4/A 25 Jul 2024 333-275409
CORRESP Open CORRESP document View SEC filing for CORRESP 25 Jul 2024
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 11 Jul 2024 377-06696
S-4/A Open S-4/A document View SEC filing for S-4/A S-4/A 14 Jun 2024 333-275409
CORRESP Open CORRESP document View SEC filing for CORRESP 14 Jun 2024
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 04 Dec 2023 377-06696
CORRESP Open CORRESP document View SEC filing for CORRESP 08 Nov 2023
S-4 Open S-4 document View SEC filing for S-4 S-4 08 Nov 2023 333-275409
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 30 May 2023 377-06696
DRS Open DRS document View SEC filing for DRS 02 May 2023 377-06696

About this filer

Liminatus Pharma, Inc. files with the SEC under CIK 0001971387. This page aggregates EDGAR filings and related ownership activity.

Industry: Biological Products, (No Disgnostic Substances).

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages